Corvus Pharmaceuticals
CRVS
#7564
Rank
โ‚น27.86 B
Marketcap
โ‚น433.67
Share price
5.92%
Change (1 day)
162.16%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -โ‚น4.76 Billion

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น2.34 Billion, an increase over its 2022 earnings that were of -โ‚น3.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น4.76 Billion103.08%
2023 -โ‚น2.34 Billion-34.57%
2022 -โ‚น3.58 Billion-4.47%
2021 -โ‚น3.75 Billion621.28%
2020 -โ‚น0.52 Billion-87.16%
2019 -โ‚น4.04 Billion-0.57%
2018 -โ‚น4.07 Billion-15.67%
2017 -โ‚น4.82 Billion53.03%
2016 -โ‚น3.15 Billion16.08%
2015 -โ‚น2.72 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น11.67 Billion 137.10%๐Ÿ‡บ๐Ÿ‡ธ USA